TP53 and glioblastoma: For example, Kinashi et al. [157] reported that DNA repair enzyme O6-methylguanine DNA methyltransferase (MGMT) and tumor suppressor p53 mutations in glioblastoma cells could affect the cell-killing effect of temozolomide combined with BNCT.